Professor Michel Chossudovsky has looked at who could ultimately benefit from current events and concludes that certain pharmaceutical companies could be (are already) major beneficiaries as they receive lavish funding to develop vaccines. He asks whether we can trust the main actors behind what could amount to a multibillion dollar global (compulsory) vaccination (surveillance) project.